chronic-diabetes Downloads
2 downloads found
Biocon Limited, publicly listed in 2004, (BSE code: 532523, NSE Id: BIOCON, ISIN Id: INE376G01013) is an innovation-led global biopharmaceuticals company committed to enhance ordable access to complex therapies for chronic conditions like diabetes, oncology and immunology. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key ...
ByBiocon
Diabetic foot ulcers and chronic venous ulcers are considered to be among the most difficult chronic wounds to treat as they typically do not respond well to standard wound closure approaches having an associated risk in minor or major ...